The presence of the genomic mutation in CDH1 indicates that the evaluation of hereditary diffuse gastric cancer and lobular breast cancer should be considered when managing follow-up [7,8,9,10,12]. This evidence concerns the gene CDH1 and Hereditary breast cancer.